FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Airway Infections May Be More Common in MS Due to Altered Immune Response in Lungs






















Disease processes in MS likely contribute to the increased sensitivity to airway infections seen in MS patients, a series of experiments in mice demonstrated.

The study, presented at the ACTRIMS 2017 Forum, showed that suppressive immune cells travel to the lungs and prevent an essential inflammatory reaction to viral infection. MS patients are known to die of infections like influenza four times more often than healthy people.

Titled “Induction of CNS-targeted autoimmunity leads to increased influenza mortality in mice,” the study was presented by Dr. Justin Glenn, of Johns Hopkins University School of Medicine, at the Young Investigator Platform Presentations Session on Feb. 23, the forum’s first day.

Glenn and colleagues figured that an immune response that targets the brain and spinal cord somehow changes the lung environment, leaving MS patients less resistant to infections such as influenza (the flu virus).

They used a mouse model of MS — the experimental autoimmune encephalomyelitis (EAE) mouse — to test this idea, infecting the animals with a mouse-adapted strain of the H1N1 influenza virus. The dose was adjusted to make sure mice would not die from the viral infection itself.

As predicted, normal mice with influenza survived, as did mice with EAE but without airway infection. But only 30 percent of the mice with both EAE and influenza infection survived.

The team next analyzed the lungs and tracked immune responses in the animals. They discovered that EAE prevented early inflammatory responses that are part of the innate immune system — the first line of defense against infections. Later immune responses, involving a specific type of T-cells, were also affected.

Investigating further, the team noted that EAE triggered the migration of a suppressive immune cell type into the lungs, where these cells suppressed the immune T-cell responses and prevented other factors, also involved in the inflammatory response, from doing their job.

Researchers also noted that the suppression of T-cells involved increased production of nitric oxide, which could be prevented by blocking the enzyme responsible for the production of this gas.

Studies have shown that the increased morbidity and mortality in airway infections among MS patients is not linked to the use of immunosuppressant medications. These findings may help to explain why, and offer researchers new opportunities to search for treatments against this process.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News